A better way to follow GLP-1 clinical trials

Save hours of research. Get daily updates on trials across all major mechanisms.

⏱️

Save Time

Stop manually checking ClinicalTrials.gov. We track all GLP-1 trials automatically.

🔄

Daily Updates

Never miss a milestone. AI agentic search gathers fresh data every day on trial status, timelines, and results.

🎯

Comprehensive

All GLP-1 mechanisms covered: mono-agonists, dual agonists, triple agonists, and more.

Pipeline visualization showing drug programs across development stages

See the entire competitive landscape at a glance

Track 100+ drug programs across all major mechanisms. Color-coded swimlane bars show development progress from Discovery to Approval.

  • Filter and sort by mechanism, phase, or company
  • Links trials to company pipelines via AI-powered matching
  • Compare development timelines across competitors
World map showing trial site distribution across countries

Know where trials are running worldwide

Interactive world map shows trial site distribution. Enrollment stats reveal trial scale and reach.

  • Site-level location data
  • Country-by-country enrollment breakdown
  • Identify geographic expansion patterns
Enrollment velocity chart with percentile comparison

Benchmark enrollment speed against the field

Velocity charts show how fast trials are recruiting. Percentile sparklines compare each trial to others in the same phase.

  • Track enrollment open/close dates automatically
  • Calculate enrollees-per-month velocity
  • See where each trial ranks vs. phase peers
Timeline view showing trial milestones and date changes

Never miss a milestone change

Uses AI to monitor trials daily and detect date changes, status updates, and result postings. Timeline view shows the complete history of each trial.

  • Automatic detection of completion date changes
  • Color-coded impact indicators (major/moderate/minor)
  • Historical record of updates
Dashboard showing curated view tabs for different trial categories

Pre-built views for what matters most

Jump straight to the trials you care about. View by commercial leaders, emerging mechanisms, or upcoming readouts. Fresh data, gathered, extracted, and transformed via AI, with rigorous expert evaluation.

  • Commercial Leaders: Top pharma and biotech programs
  • Emerging Mechanisms: Dual and triple agonists, amylin combos
  • Upcoming Readouts: Trials with results expected soon
Results tab showing trial efficacy and safety findings

See results as soon as they're out

Efficacy and safety findings extracted via agentic search and cited for easy verification. Structured data makes it easy to compare outcomes across trials.

  • Primary and secondary endpoint results
  • Safety and adverse event summaries
  • Links to full publications and press releases